A

Annovis Bio
D

ANVS

2.72500
USD
-0.01
(-0.18%)
مغلق
حجم التداول
5,514
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
53,099,979
أصول ذات صلة
ALNY
ALNY
6.65
(1.50%)
449.19 USD
ASND
ASND
6.320
(3.29%)
198.340 USD
C
CRBP
-0.26000
(-2.72%)
9.31000 USD
E
EYPT
0.255
(2.35%)
11.100 USD
V
VKTX
-0.230
(-0.57%)
40.030 USD
المزيد
الأخبار المقالات

العنوان: Annovis Bio

القطاع: Healthcare
الصناعة: Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.